GETINGE Return on Tangible Equity 2016-2023 | GNGBY
Current and historical return on tangible equity values for GETINGE (GNGBY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| GETINGE Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-09-30 | $0.21B | $0.38B | 61.14% |
| 2023-06-30 | $0.21B | $0.29B | 65.23% |
| 2023-03-31 | $0.25B | $0.38B | 84.83% |
| 2022-12-31 | $0.25B | $0.34B | 100.51% |
| 2022-09-30 | $0.28B | $0.25B | 147.51% |
| 2022-06-30 | $0.29B | $0.19B | 184.28% |
| 2022-03-31 | $0.33B | $0.21B | 270.81% |
| 2021-12-31 | $0.35B | $0.12B | 456.58% |
| 2021-09-30 | $0.38B | $0.12B | 1270.59% |
| 2021-06-30 | $0.45B | $0.04B | -861.84% |
| 2021-03-31 | $0.40B | $0.03B | -268.90% |
| 2020-12-31 | $0.35B | $-0.07B | -138.16% |
| 2020-09-30 | $0.33B | $-0.21B | -101.30% |
| 2020-06-30 | $0.20B | $-0.35B | -50.00% |
| 2020-03-31 | $0.16B | $-0.40B | -36.85% |
| 2019-12-31 | $0.13B | $-0.35B | -29.15% |
| 2019-09-30 | $0.11B | $-0.48B | -23.44% |
| 2019-06-30 | $-0.07B | $-0.48B | 13.91% |
| 2019-03-31 | $-0.07B | $-0.48B | 14.55% |
| 2018-12-31 | $-0.11B | $-0.51B | 23.03% |
| 2018-09-30 | $-0.07B | $-0.57B | 14.99% |
| 2018-06-30 | $0.10B | $-0.45B | -20.89% |
| 2018-03-31 | $0.09B | $-0.42B | -13.78% |
| 2017-12-31 | $0.16B | $-0.38B | -18.55% |
| 2017-09-30 | $0.15B | $-0.69B | -13.31% |
| 2017-06-30 | $0.13B | $-1.18B | -11.30% |
| 2017-03-31 | $0.16B | $-1.22B | -14.35% |
| 2016-12-31 | $0.14B | $-1.30B | -13.92% |
| 2016-09-30 | $0.14B | $-0.91B | -14.31% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.000B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.475B | 15.37 |
| Cencora (COR) | United States | $44.674B | 17.41 |
| ICON (ICLR) | Ireland | $25.493B | 24.07 |
| DiDi Global (DIDIY) | China | $24.448B | 0.00 |
| Avantor (AVTR) | United States | $16.791B | 24.72 |
| Viatris (VTRS) | United States | $14.026B | 4.03 |
| CochLear (CHEOY) | Australia | $13.917B | 0.00 |
| Revvity (RVTY) | United States | $12.428B | 21.78 |
| Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
| Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
| Natera (NTRA) | United States | $11.711B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
| Solventum (SOLV) | United States | $11.153B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
| HealthEquity (HQY) | United States | $6.740B | 50.35 |
| Organon (OGN) | United States | $5.043B | 4.78 |
| Bausch + Lomb (BLCO) | Canada | $4.779B | 19.16 |
| Doximity (DOCS) | United States | $4.494B | 33.46 |
| PACS (PACS) | United States | $3.725B | 0.00 |
| Sotera Health (SHC) | United States | $3.119B | 15.31 |
| Surgery Partners (SGRY) | United States | $3.118B | 28.86 |
| Progyny (PGNY) | United States | $3.049B | 51.16 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.783B | 29.48 |
| Premier (PINC) | United States | $2.460B | 9.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
| Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.970B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Alignment Healthcare (ALHC) | United States | $1.268B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
| Embecta (EMBC) | United States | $0.584B | 3.86 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.514B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| CareDx (CDNA) | United States | $0.503B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| MultiPlan (MPLN) | United States | $0.422B | 0.00 |
| Beauty Health (SKIN) | United States | $0.415B | 0.00 |
| ModivCare (MODV) | United States | $0.383B | 7.18 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
| Sharecare (SHCR) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.161B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.080B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |